Optimized Roflumilast Ethosomal Gel for Enhanced Transdermal Therapy in Atopic Dermatitis: An In Vitro Study
ChemistryOpen · 2026-11 · 15 (11)
DOI: 10.1002/open.70335 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistryOpen, online erschienen am 11.11.2026. Verfasst von Yasir Mehmood und 11 weiteren Autor:innen. Beteiligte Einrichtung: Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University, Faisalabad, Pakistan. Hauptthemen laut MEDLINE: Aminopyridines, Benzamides, Dermatitis, Atopic. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ongoing Research Funding Program, King Saud University Riyadh, Saudi Arabia.
Abstract (Originalsprache)
This study evaluated a transdermal drug delivery system using roflumilast (RT)‐loaded ethosomal gel for the topical treatment of inflammatory skin disorders. RT‐loaded ethosomes were prepared using the cold method and incorporated into a topical gel. Eight formulations were developed and optimized using a Design of Experiments approach to investigate the effects of formulation variables on drug entrapment and performance. Among them, RT‐5 was selected as the optimized formulation and evaluated for physicochemical properties, stability, microbiological quality, drug release, and transdermal permeation. RT‐5 exhibited suitable topical characteristics, including a pH of 5.3–5.5, viscosity of 90–91 cP, and good spreadability. In vitro diffusion studies at pH 5.5 showed 25.5% ± 3% drug release within the first hour compared with 5.2% ± 2% from the commercial cream. Moreover, RT‐5 achieved cumulative drug penetration of 99.34% after 12 h, demonstrating enhanced transdermal delivery. Stability studies showed that the formulation maintained acceptable pH, viscosity, consistency, and appearance for 6 months under recommended storage conditions and at least 3 months under accelerated conditions. Microbiological testing revealed no detectable bacterial growth. The outcome of this work showed that RT‐5 demonstrated satisfactory stability, quality, and improved transdermal delivery of roflumilast.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Riphah Institute of Pharmaceutical Sciences (RIPS), Riphah International University, Faisalabad, Pakistan.
- Department of Biochemistry, Faculty of Sciences, University of Agriculture Faisalabad, Faisalabad, Punjab, Pakistan.
- Department of Biochemistry, Riphah International University, Faisalabad, Pakistan.
- Department of Pharmacology, Faculty of Pharmaceutical Sciences, GC University Faisalabad, Faisalabad, Pakistan.
- National Federation of Associations of Medical Practitioners in Chad (FENAPMT), Ministry of Health, N'Djamena, Republic of Chad.
- Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen campus, Tsinghua University, Shenzhen, China.
ORCID-Profile: Atika Javed, Hamza Rafeeq, Ousman Brahim Mahamat, Gamal A Shazly, Musa A Said
Förderung
- Ongoing Research Funding Program, King Saud University Riyadh, Saudi Arabia
Zitieren
APA
Mehmood, Y., Rizvi, S. M., Javed, A., Siddique, R., Rafeeq, H., Shahid, H., Mahamat, O. B., Zohaib, H. M., Almaary, K. S., Shazly, G. A., Said, M. A., & Dawoud, T. M. (2026). Optimized Roflumilast Ethosomal Gel for Enhanced Transdermal Therapy in Atopic Dermatitis: An In Vitro Study. ChemistryOpen, 15(11). https://doi.org/10.1002/open.70335
Vancouver
Mehmood Y, Rizvi SM, Javed A, Siddique R, Rafeeq H, Shahid H, et al. Optimized Roflumilast Ethosomal Gel for Enhanced Transdermal Therapy in Atopic Dermatitis: An In Vitro Study. ChemistryOpen. 2026;15(11). doi:10.1002/open.70335
BibTeX
@article{Mehmood2026,
author = {Mehmood, Yasir and Rizvi, Syeda Momena and Javed, Atika and Siddique, Rida and Rafeeq, Hamza and Shahid, Hira and Mahamat, Ousman Brahim and Zohaib, Hafiz Muhammad and Almaary, Khalid S and Shazly, Gamal A and Said, Musa A and Dawoud, Turki M},
title = {Optimized Roflumilast Ethosomal Gel for Enhanced Transdermal Therapy in Atopic Dermatitis: An In Vitro Study},
journal = {ChemistryOpen},
year = {2026},
volume = {15},
number = {11},
doi = {10.1002/open.70335}
}
EUVIMED